Company Monitoring Page for Incyte

latest headlines for company on cafepharma

FDA to quickly review Incyte’s Jakafi in chronic GVHD
Pharmaforum
Tue, 02/23/21 - 10:42 am
Tags:
FDA, Incyte, Jakafi, graft vs host disease
Incyte Says FDA Grants Priority Review For Eczema Cream
Yahoo/SmarterAnalyst
Mon, 02/22/21 - 11:00 am
Tags:
Incyte, eczema, FDA, priority review, ruxolitinib
What's Behind Incyte's Better-Than-Expected Q4 Earnings
Motley Fool
Tue, 02/9/21 - 11:57 pm
Tags:
Incyte, earnings
Incyte makes bid to join the checkpoint inhibitor club
Pharmaforum
Tue, 02/2/21 - 10:25 am
Tags:
Incyte, FDA, retifanlimab, anal cancer, HIV, HPV
Incyte lands priority review for PD-1 inhibitor in anal cancer
Fierce Biotech
Fri, 01/22/21 - 10:31 am
Tags:
Incyte, FDA, priority review, anal cancer, retifanlimab
JPM: Established relationships were key to pandemic drug launches, Incyte CEO says
Fierce Pharma
Sat, 01/16/21 - 11:48 pm
Tags:
COVID-19, pandemic, drug launches, Incyte, JPMHC 2021
Novartis/Incyte draw blank with Jakafi in COVID-19
Pharmaforum
Mon, 12/14/20 - 10:35 am
Tags:
Novartis, Incyte, Jakafi, COVID-19, clinical trials
EADV 2020: Lilly and Incyte Showcase New Data for Baricitinib for the Treatment of Moderate to Severe Atopic Dermatitis
Yahoo
Sun, 11/1/20 - 01:37 pm
Tags:
Eli Lilly, Incyte, baricitinib, atopic dermatitis, EADV
Shares of Lilly and Incyte gain after late-stage study finds their arthritis drug can help reduce COVID-19 recovery time
Marketwatch
Mon, 09/14/20 - 10:21 am
Tags:
Eli Lilly, Incyte, olumiant, COVID-19, remdesivir, Gilead Sciences
Karuna and Incyte scrap programs; More cash for the SPACs
Endpoints
Wed, 08/5/20 - 12:02 am
Tags:
Karuna Therapeutics, Eli Lilly, Incyte, SPAC
FDA approves MorphoSys, Incyte’s drug for vulnerable lymphoma population
MedCity News
Mon, 08/3/20 - 10:14 am
Tags:
FDA, Monjuvi, CAR-T, MorphoSys, Incyte, diffuse large B-cell lymphoma
Ruxolitinib passes another PhIII test for graft-versus-host disease, a win for Incyte and Novartis
Endpoints
Thu, 07/23/20 - 11:06 am
Tags:
ruxolitinib, Novartis, Incyte, graft vs host disease
Why Incyte's Q1 Loss Isn't As Bad As It Looks
Motley Fool
Tue, 05/5/20 - 11:52 pm
Tags:
Incyte, earnings
#AACR20: Early data suggest Novartis' Incyte-discovered MET inhibitor helps lung cancer patients with brain lesions
Endpoints
Mon, 04/27/20 - 09:43 am
Tags:
Novartis, Incyte, AACR, lung cancer, MET inhibitors, capmatinib
Novartis, Incyte's Jakafi boosts its case in graft-versus-host disease with another phase 3 win
Fierce Pharma
Wed, 04/22/20 - 10:45 pm
Tags:
Novartis, Incyte, Jakafi, clinical trials, COVID-19, cytokine storm, graft vs host disease
Incyte nabs 2nd ever approval ahead of schedule as FDA insists it can still review on time
Endpoints
Mon, 04/20/20 - 10:58 am
Tags:
Incyte, Pemazyre, pemigatinib, bile duct cancer, cholangiocarcinoma, FDA
Incyte, Novartis launch drug study to treat coronavirus complication
Marketwatch
Sat, 04/18/20 - 11:22 pm
Tags:
Incyte, Novartis, cytokine storm, COVID-19, clinical trials, Jakafi
Incyte to Test Its Cancer Drug Jakafi as a Treatment for COVID-19
Motley Fool
Fri, 04/3/20 - 12:02 am
Tags:
cancer, COVID-19, Incyte, Jakafi
Lilly, Incyte get FDA breakthrough therapy status for baricitinib to treat alopecia areata
Pharmaceutical Business Review
Tue, 03/17/20 - 11:59 am
Tags:
Eli Lilly, Incyte, breakthrough therapy, FDA, baricitinib, alopecia areata
Incyte hits endpoint in 2nd pivotal atopic dermatitis trial
Fierce Biotech
Wed, 02/19/20 - 09:58 am
Tags:
Incyte, ruxolitinib, clinical trials, atopic dermatitis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.